how to buy and sell digital currency, Block

OPEC Monthly Report: Russia slightly cut its oil production in November. On Wednesday, OPEC quoted data from second-hand sources as saying that Russia's crude oil production in November decreased slightly by 0.7 million barrels per day to about 8.99 million barrels per day. This is basically consistent with Russia's monthly production quota of 8.98 million barrels under the OPEC+agreement (including voluntary production reduction). Russia promised to cut production in October and November this year and from March to September next year to make up for the excess production since April. The output of Iraq and Kazakhstan has also been higher than the target, and they also promised to further reduce production to compensate for their excess production.The US Department of Commerce listed two high-tech enterprises in China on the list of entities on the grounds of "human rights violations", and the Foreign Ministry responded that the Foreign Ministry of China held a regular press conference today (11th). At the meeting, the CCTV reporter asked questions. On December 10th, the US Department of Commerce listed two high-tech enterprises in China on the "entity list" on the grounds of "human rights violation". What is China's comment? In this regard, Mao Ning said that the so-called sanctions you mentioned are a blatant crackdown on China's high-tech enterprises under the guise of human rights, which further exposes that the US side's protection of human rights is false and depriving the China people of their right to development is true. This trick can't succeed. If the United States really cares about human rights, it should first make up its own human rights "debt", instead of politicizing and weaponizing human rights issues, interfering in other countries' internal affairs and harming other countries' interests everywhere. (CCTV News)Blonde Technology: Shareholders holding more than 5% of the shares plan to transfer 2% of the shares internally. Blonde Technology announced that as of the announcement date, Ms. Xiong Haitao, a shareholder, holds 122 million shares of the company, accounting for 4.64% of the company's total share capital; Ms. Xiong Haitao and her concerted actions hold a total of 216 million shares, accounting for 8.2% of the total share capital. Ms. Xiong Haitao plans to sign an agreement with Warburg Wanying Private Equity Fund to increase it as a concerted action, and plans to transfer no more than 52.73 million shares to it through block trading, that is, no more than 2% of the total share capital. After the transfer is completed, Huabao Wanying will entrust Ms. Xiong Haitao with the right to vote on the shares. This internal transfer does not involve market reduction, and the shareholding ratio remains unchanged, which does not affect the company's control.

Modern Investment: Xu Qing, the independent director of the company, was subject to disciplinary review and supervision investigation. According to the announcement of Modern Investment, Xu Qing, the independent director of the company, was suspected of serious violation of discipline and law, and is currently subject to disciplinary review by the Disciplinary Committee of Hunan Branch of Industrial and Commercial Bank of China and supervision investigation by Zhuzhou Municipal Supervision Committee. Xu Qing did not hold any other positions in the company except as an independent director, chairman of the Nomination Committee of the Board of Directors, member of the Strategy Committee of the Board of Directors and member of the Audit Committee of the Board of Directors, and did not participate in the daily operation and management of the company. The company will pay attention to the subsequent progress and fulfill its information disclosure obligations in a timely manner in strict accordance with relevant regulations.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)India's new central bank governor: policy stability is very important and will try to maintain policy continuity.

Senior energy safety official: Poland will start looking for partners for the construction of the second nuclear power plant in early 2025.HSBC is studying plans to cut costs by at least $3 billion. On December 11th, it was reported that HSBC Holdings was studying plans to cut costs by at least $3 billion. According to people familiar with the matter, HSBC told managers last week that its reform would not be completed until June 2025. These people said that the total cost savings are still in progress, but executives hope that this work will help them reduce their expenses by at least $3 billion.Kremlin: We keep in touch with those who control the situation in Syria.